Response to the letter entitled “COPD-and-smoking-induced ‘down regulation’ of CO2-related vasoconstriction in the brain during CPAP for sleep apnea may paradoxically reduce risk of cardiovascular events”

A Basic Science • Letter to the Editors to this article was published on 26 February 2020

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Jaster JH. COPD-and-smoking-induced ‘down regulation’ of CO2-related vasoconstriction in the brain during CPAP for sleep apnea may paradoxically reduce risk of cardiovascular events. https://doi.org/10.1007/s11325-020-02027-y

  2. 2.

    Myllylä M, Hammais A, Stepanov M, Anttalainen U, Saaresranta T, Laitinen T (2019) Nonfatal and fatal cardiovascular disease events in CPAP compliant obstructive sleep apnea patients. Sleep Breath 23:1209–1217

    Article  Google Scholar 

  3. 3.

    Brandon TH, Vidrine JI, Litvin EB (2007) Relapse and relapse prevention. Annu Rev Clin Psychol 3:257–284

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Minna Myllylä.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Myllylä, M., Hammais, A., Stepanov, M. et al. Response to the letter entitled “COPD-and-smoking-induced ‘down regulation’ of CO2-related vasoconstriction in the brain during CPAP for sleep apnea may paradoxically reduce risk of cardiovascular events”. Sleep Breath 24, 1183–1185 (2020). https://doi.org/10.1007/s11325-020-02028-x

Download citation